Conference Call Scheduled Today at 11a.m. ET
Chembio Diagnostics, Inc. (OTCBB: CEMI)
("Chembio" or the "Company") today announced that it has completed its plan
(the "Plan") to simplify...
Dutton Associates updates its coverage of Chembio Diagnostics Inc.
(OTCBB: CEMI), maintaining its rating of Strong Speculative Buy and
assigning a 12-month price target of $1.00....
Timely Diagnosis Is Critical for Successful Treatment of Emerging Infectious DiseaseChembio Diagnostics, Inc. (OTCBB: CEMI) has been awarded a Small Business Innovative Research Phase I grant in...
NEW YORK--(BUSINESS WIRE)--(OTCBB:CEMI) – Chembio’s two FDA-approved rapid HIV tests have been launched in the U.S. market and are available exclusively through Inverness...
NEW YORK--(BUSINESS WIRE)--(OTCBB:CEMI) - Chembio Diagnostics, Inc. has received a Notice of
Allowance from the United States Patent and Trademark Office for its
Dual Path Immunoassay...
NEW YORK--(BUSINESS WIRE)--(OTCBB:CEMI) - Avi Pelossof, Chembio’s Vice
President of Sales, Marketing and Business Development, has resigned
from Chembio to accept a new position...
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Dutton Associates updates its coverage of Chembio Diagnostics
(OTCBB:CEMI) maintaining a Strong Speculative Buy rating and a 12 month
$1.50...
NEW YORK--(BUSINESS WIRE)--Chembio Diagnostics, Inc.’s (OTCBB:CEMI)
Lawrence Siebert, President and Chief Executive Officer, was interviewed
by television and radio stations...
MEDFORD, N.Y.--(BUSINESS WIRE)--Chembio Diagnostics Inc. (OTCBB: CEMI) has received CLIA Waiver for one
of its two FDA-approved rapid HIV tests, HIV 1/2 STAT-PAK™.
The CLIA...
MEDFORD, N.Y.--(BUSINESS WIRE)--Chembio Diagnostics, Inc. (OTCBB:CEMI) has signed a Cooperative Research
and Development Agreement (CRADA) with the United States Centers for
Disease...
NEW YORK--(BUSINESS WIRE)--
In the financial table, the Accreted Beneficial Conversion to preferred
stock for Third Quarter 2006 should read: 538,560 (sted
538,650), and...
MEDFORD, N.Y.--(BUSINESS WIRE)--Chembio Diagnostics, Inc. (OTCBB:CEMI) has received a purchase order for
990,000 of its SURE CHECK® HIV 1/2 rapid tests
from the Company’s...
#23: CEMI News Chembio Diagnostics to Present at the Paulson Investment's Westergaard Small Cap Conference November 6 and the Rodman & Renshaw Healthcare Conference on November 8, 2006
NEW YORK--(BUSINESS WIRE)--Chembio Diagnostics, Inc.’s (OTCBB:CEMI)
Lawrence Siebert, President and Chief Executive Officer, will be
presenting at Paulson Investment’s...
NEW YORK--(BUSINESS WIRE)--First graph, first sentence, the presentation time should read: 3:00 PM
(EST) sted: (3:30 PM (EST)).
The corrected release reads:
...
NEW YORK--(BUSINESS WIRE)--Chembio Diagnostics, Inc. (OTCBB:CEMI) will host a conference call
today, Tuesday October 10th at 4:30pm ET to
discuss the recently announced financing and...
